NEU 3.15% $21.27 neuren pharmaceuticals limited

The rationale behind the consolidation was to make the shares...

  1. GC8
    1,890 Posts.
    lightbulb Created with Sketch. 3
    The rationale behind the consolidation was to make the shares suitable for Instos to buy in accordance with their mandates ie: SP value $1>. However, someone obviously left the Instos out of the loop because they either don't know about good old NEU or if they do they certainly won't pay up at current retail prices.
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
(20min delay)
Last
$21.27
Change
0.650(3.15%)
Mkt cap ! $2.718B
Open High Low Value Volume
$20.84 $21.56 $20.76 $7.760M 364.5K

Buyers (Bids)

No. Vol. Price($)
2 1378 $21.24
 

Sellers (Offers)

Price($) Vol. No.
$21.29 218 1
View Market Depth
Last trade - 16.10pm 28/06/2024 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.